John Melvyn Davies
Oprichter bij Melvyn Davies & Co. Ltd.
Oorsprong van het eerstegraads netwerk van John Melvyn Davies
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 18 | |
| Public Company | Pharmaceuticals: Other | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John Melvyn Davies via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Corporate Officer/Principal | |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Biotechnology | Director/Board Member | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TVAX BIOM | Biotechnology | Chief Executive Officer | |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Director/Board Member President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| E-THERAPEUTICS PLC | Biotechnology | Chairman Chief Operating Officer | |
| University of Virginia | College/University | Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree | |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder | |
| The University of Southampton | College/University | Undergraduate Degree | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Graduate Degree | |
| University of North Dakota | College/University | Graduate Degree | |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Doctorate Degree | |
| Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ACMP IV LLC | Director/Board Member | ||
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Founder | |
| FHM Life Sciences VIII LLC | Corporate Officer/Principal | ||
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member | |
| PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pantherna Therapeutics GmbH
 Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Chameleon Biosciences, Inc.
 Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Biotechnology | Founder | |
Seraxis Holdings, Inc.
 Seraxis Holdings, Inc. Financial ConglomeratesFinance Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust. | Financial Conglomerates | Director/Board Member | |
Voyager Life Plc
 Voyager Life Plc Pharmaceuticals: OtherHealth Technology Voyager Life Plc engages in health and wellness business focused on CBD and hemp seed oil products. It offers CBD Gummies, skin, bath & pet products. The company was founded by Nicholas George Selby Tulloch on November 12, 2020, and is headquartered in Perth, the United Kingdom. | Pharmaceuticals: Other | Chairman Founder | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Verenigd Koninkrijk | 6 |
| Duitsland | 5 |
| Canada | 2 |
| Israël | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Finance | 3 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 175 |
| Corporate Officer/Principal | 53 |
| Chairman | 50 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| Jeremy Curnock-Cook | 60 |
| James Topper | 52 |
| Iain Ross | 41 |
| David Mack | 19 |
| Robert Price | 17 |
| Barbara Ruskin | 12 |
| Jeremy Randall | 10 |
| Nicholas Tulloch | 10 |
| Annette Clancy | 10 |
| Philip Haworth | 10 |
| Xiao Dong Yang | 9 |
| Bernd O. Wetzel | 8 |
| Klaus Giese | 7 |
| Eric James Boyle | 7 |
| Michael Riley | 6 |
- Beurs
- Insiders
- John Melvyn Davies
- Bedrijfsconnecties
